生物活性
T0070907是一种有效的,选择性的PPARγ抑制剂,IC50为1 nM,比作用于PPARα和PPARδ选择性高800倍以上。T0070907是一种强有效和选择性的PPARγ抑制剂。具有明显的亲和性,IC50为1 nM。T0070907共价结合在 PPARγ 313位的半胱氨酸螺旋3上。
化学数据
分子量 |
277.66 |
分子式 |
C12H8ClN3O3 |
CAS号 |
313516-66-4 |
纯度 |
99.73% |
溶解性(25°C) |
DMSO 13 mg/mL |
储存和运输条件 |
固体粉末: -20°C 冷藏长期储存 常温运输及临时存放 |
实验操作来自于公开的文献,仅供相同实验参考(如实验材料、目的不同,请参考其他文献)
细胞实验 |
细胞系 |
Vascular endothelial cells (VECs) |
方法 |
Cellular impedance assay VEC proliferation was assessed using a cellular impedance assay. VECs were seeded into 8-well E-plates (ACEA Biosciences, Inc., San Diego, CA, USA) at a density of 7,500 cells/well and cultured overnight. Cells were cultured with complete medium, supplemented with 0.1% dimethyl sulfoxide (DMSO) as a control, the PPARγ agonist rosiglitazone (10 μM) or the PPARγ antagonist T0070907 (15 μM) respectively, as previously described. Cellular proliferation was dynamically monitored using the iCELLigence(TM) real-time cell analysis (RTCA) system (ACEA Biosciences, Inc.) at 37°C in a 5% CO2 atmosphere for 100 h. The cell index, which reflects the adhesion, proliferation and viability of the cells through electrical impedance across interdigitated microelectrodes integrated on the bottom of the E-plates, was automatically calculated for each E-plate well using RTCA software version 1.2 (Roche Diagnostics, Basel, Switzerland) and graphs were generated in real-time using the iCELLigence(TM) system (30,31). Each treatment was performed in duplicate and three independent experiments were conducted. |
浓度 |
15 μM |
处理时间 |
24 h |
动物实验 |
动物模型 |
Preconditioning is performed by administering a low dose (1 mg/kg) of Escherichia coli LPS (serotype 0.127:B8) intraperitoneally 24 hr before the induction of severe endotoxemia |
配制 |
10% v/v dimethylsulfoxide [DMSO], 20–25% v/v DMSO, or saline |
剂量 |
1 mg/kg |
给药处理 |
intraperitoneally |
不同实验动物依据体表面积的等效剂量转换表(数据来源于FDA指南)
|
小鼠 |
大鼠 |
兔 |
豚鼠 |
仓鼠 |
狗 |
重量 (kg) |
0.02 |
0.15 |
1.8 |
0.4 |
0.08 |
10 |
体表面积 (m2) |
0.007 |
0.025 |
0.15 |
0.05 |
0.02 |
0.5 |
Km系数 |
3 |
6 |
12 |
8 |
5 |
20 |
动物 A (mg/kg) = 动物 B (mg/kg) × |
动物 B的Km系数 |
动物 A的Km系数 |
例如,依据体表面积折算法,将化合物用于小鼠的剂量20 mg/kg 换算成大鼠的剂量,需要将20 mg/kg 乘以小鼠的Km系数(3),再除以大鼠的Km系数(6),得到化合物用于大鼠的等效剂量为10 mg/kg。
储备液配制
以下数据基于半岛bd体育手机客户端 分子量,对于特殊半岛bd体育手机客户端 ,请参照COA中的储备液配制条件和说明进行操作。
Concentration / Solvent Volume / Mass |
1 mg |
5 mg |
10 mg |
1 mM |
3.6015 mL |
18.0076 mL |
36.0153 mL |
5 mM |
0.7203 mL |
3.6015 mL |
7.2031 mL |
10 mM |
0.3602 mL |
1.8008 mL |
3.6015 mL |